Trials / Unknown
UnknownNCT04026724
Retrospective Clinical Study on Adjuvant Treatment of Coronary Heart Disease Angina Pectoris With Chinese Patent Medicine
Retrospective Cohort Study on Adjuvant Treatment of Coronary Heart Disease Angina Pectoris With Chinese Patent Medicine
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 12,400 (estimated)
- Sponsor
- Tianjin University of Traditional Chinese Medicine · Academic / Other
- Sex
- All
- Age
- 35 Years – 75 Years
- Healthy volunteers
- —
Summary
A retrospective cohort study was performed in patients with angina pectoris who were treated with oral Chinese patent medicine and Western medicine.The hospital's medical record management system was used to collect symptoms of angina pectoris, dose and frequency of nitroglycerin use, clinical biochemical test and imaging examination.To explore the clinical efficacy of Chinese patent medicine in the treatment of coronary heart disease with angina pectoris, and provide reliable data support for its clinical application.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chinese patent medicine | Shexiang Baoxin Pill, Tongxinluo Capsule, Tongmai Yangxin Pill, Xuefu Zhuyu Capsule, Qishen Yiqi Dropping Pill. |
Timeline
- Start date
- 2019-09-01
- Primary completion
- 2020-03-01
- Completion
- 2020-09-01
- First posted
- 2019-07-19
- Last updated
- 2019-07-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04026724. Inclusion in this directory is not an endorsement.